Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076219 · ClinicalTrials.gov registry record · Phase 3
Acute Renal Failure Trial Network (ATN) Study
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,124
- Enrollment target
NCT00076219 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,124 participants.
The verdict
NCT00076219, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,124 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, randomized, parallel-group trial of an intensive strategy vs conventional strategy of renal replacement therapy for the treatment of acute renal failure secondary to acute tubular necrosis in critically ill patients. The primary hypothesis is that the intensive strategy will reduce 60-day all cause mortality by 10% compared to the conventional strategy - i.e.,a reduction from 55% in the conventional arm to 45% in the intensive arm. Secondary outcomes are 60-day in-hospital all-cause mortality, 1-year all cause mortality, and recovery of renal function by day 28. The study will recruit 1164 patients over a period of 3 years, 8 months and each patient will be actively followed for 60 days.
Interventions
- PROCEDURE renal replacement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,124 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00076219
The ClinicalTrials.gov registry entry for NCT00076219 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which renal replacement therapy is the first listed.
NCT00076219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00076219 about?
NCT00076219 is a clinical study titled "Acute Renal Failure Trial Network (ATN) Study". This is a multi-center, prospective, randomized, parallel-group trial of an intensive strategy vs conventional strategy of renal replacement therapy for the treatment of acute renal failure secondary to acute tubular necrosis in critically ill patients. The primary hypothesis is that the intensive s...
What is the current status of trial NCT00076219?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,124 participants. The study started on 2003-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00076219?
The interventions under investigation include: renal replacement therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00076219?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.